These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 4078706)

  • 1. Action of hydrochloric acid on aluminum hydroxide-magnesium hydroxide gels and magaldrate: 27Al NMR and pH-stat studies.
    Wilson GE; Falzone CJ; Johnson R; Lee HK
    J Pharm Sci; 1985 Oct; 74(10):1075-7. PubMed ID: 4078706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action of hydrochloric acid on aluminum hydroxide-magnesium hydroxide gels and magaldrate: quasi-elastic light scattering studies.
    Guterman LR; Falzone J; Wilson GE
    J Pharm Sci; 1986 May; 75(5):502-5. PubMed ID: 3735091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of neutralizing properties of antacid preparations. Part 7. 27Al NMR studies of aluminum species formed during acid dissolution of some antacid preparations.
    Kokot Z
    Pharmazie; 1989 Dec; 44(12):828-30. PubMed ID: 2635320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of neutralizing properties of antacid preparations. Part 3: Constant pH neutralization of hydrochloric acid by hydrotalcite.
    Kokot Z
    Pharmazie; 1988 Apr; 43(4):249-51. PubMed ID: 3413211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of hydrotalcite in mixtures of aluminum hydroxycarbonate and magnesium hydroxide gels.
    Vanderlaan RK; White JL; Hem SL
    J Pharm Sci; 1982 Jul; 71(7):780-6. PubMed ID: 7120062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a new antacid, almagate.
    Beneyto JE; Fábregas JL; Moragues J; Spickett RG
    Arzneimittelforschung; 1984; 34(10A):1350-4. PubMed ID: 6439224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of antacid suspensions containing aluminum hydroxide and magnesium hydroxide.
    Hem SL; White JL; Buehler JD; Luber JR; Grim WM; Lipka EA
    Am J Hosp Pharm; 1982 Nov; 39(11):1925-30. PubMed ID: 7148862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of antacid compounds containing both aluminum and magnesium. II. Codried powders.
    Peterson CL; Perry DL; Masood H; White JL; Hem SL; Fritsch C; Haeusler F
    Pharm Res; 1993 Jul; 10(7):1005-7. PubMed ID: 8378241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of almagate and pharmaceutical formulations prepared from it.
    Fábregas JL; Beneyto JE
    Arzneimittelforschung; 1984; 34(10A):1354-7. PubMed ID: 6548919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of antacid compounds containing both aluminum and magnesium. I. Crystalline powders.
    Peterson CL; Perry DL; Masood H; Lin H; White JL; Hem SL; Fritsch C; Haeusler F
    Pharm Res; 1993 Jul; 10(7):998-1004. PubMed ID: 8378263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of composition on the neutralizing properties of antacid preparations.
    Pawlaczyk J; Lutka A; Kokot Z
    Pharmazie; 1984 May; 39(5):334-6. PubMed ID: 6473495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of interaction of aluminum hydroxycarbonate gel and magnesium hydroxide gel on acid neutralization.
    Vanderlaan RK; White JL; Hem SL
    J Pharm Sci; 1979 Dec; 68(12):1498-501. PubMed ID: 43385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of buffering capacity and acid neutralizing-pH time profile of antacids.
    Lin MS; Sun P; Yu HY
    J Formos Med Assoc; 1998 Oct; 97(10):704-10. PubMed ID: 9830281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug interactions during storage of mixtures of the antacid group. III. Effect of relative humidity on structural changes in mixtures aluminum hydroxide gel and magnesium hydroxide in the solid phase].
    Pawlaczyk J; Lutka A
    Acta Pol Pharm; 1989; 46(2):170-3. PubMed ID: 2631571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neutralizing capacity, pepsin inactivation and binding to bile acids and lysolecithin of the antacid magaldrate (author's transl)].
    Baur C; Becker A; Linder R; Schwan T
    Arzneimittelforschung; 1981; 31(3):504-7. PubMed ID: 6784737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of proteolytic enzymes and polypeptides on the antacid activity of almagate and other antacids.
    Beneyto JE; Fábregas JL
    Arzneimittelforschung; 1984; 34(10A):1357-60. PubMed ID: 6391496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium content of maalox.
    Hazelwood D; Martinez DR
    Am J Hosp Pharm; 1976 Nov; 33(11):1127. PubMed ID: 998625
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of magaldrate on circadian profile of gastric juice pH in medical intensive care patients (author's transl)].
    Dammann HG; Flashoff D; Müller P; Kather H; Simon B
    Dtsch Med Wochenschr; 1981 Oct; 106(44):1457-8. PubMed ID: 7297433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antacids--gel or tablet. A randomized, double-blind, placebo-controlled study].
    Schulthess HK; Häcki WH
    Schweiz Med Wochenschr; 1985 Jul; 115(29):1016-9. PubMed ID: 4048899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-stat titration of aluminum hydroxide gel.
    Kerkhof NJ; Vanderlaan RK; White JL; Hem SL
    J Pharm Sci; 1977 Nov; 66(11):1528-33. PubMed ID: 21278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.